Industrial perspectives on brain-computer interface technology
Neuromodulation therapies offer a unique opportunity for translating brain-computer interface (BCI) technologies into a clinical setting. Several diseases such as Parkinson's disease are effectively treated by invasive device stimulation therapies, and the addition of sensing and algorithm tech...
Saved in:
Published in | Handbook of Clinical Neurology Vol. 168; pp. 341 - 352 |
---|---|
Main Authors | , , |
Format | Book Chapter Journal Article |
Language | English |
Published |
Netherlands
Elsevier Health Sciences
2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Neuromodulation therapies offer a unique opportunity for translating brain-computer interface (BCI) technologies into a clinical setting. Several diseases such as Parkinson's disease are effectively treated by invasive device stimulation therapies, and the addition of sensing and algorithm technology is an obvious evolutionary expansion of capabilities. In addition, this infrastructure might enable a roadmap of novel BCI technologies. While the initial applications are focused on epilepsy and movement disorders, the technology is potentially transferable to a broader base of disorders, including stroke and rehabilitation. The ultimate potential of BCI technology will be determined by forthcoming chronic evaluation in multiple neurologic disorders. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISBN: | 9780444639349 0444639349 |
ISSN: | 0072-9752 |
DOI: | 10.1016/B978-0-444-63934-9.00025-1 |